MET and Small-Cell Lung Cancer

by Gelsomino, Francesco, Rossi, Giulio, Tiseo, Marcello
Published in Cancers (Basel) (2014)

Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements

by Gelsomino, Francesco, Rossi, Giulio, Tiseo, Marcello
Published in J Thorac Dis (2015)

DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients’ clinical management and be a therapeutic target?

by Lamberti, Giuseppe, Peterle, Chiara, Gelsomino, Francesco
Published in Transl Lung Cancer Res (2018)

Innate host responses to West Nile virus: Implications for central nervous system immunopathology

by Rossini, Giada, Landini, Maria Paola, Gelsomino, Francesco, Sambri, Vittorio, Varani, Stefania
Published 2013

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

by Raschi, Emanuel, Gatti, Milo, Gelsomino, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Published in Target Oncol (2020)

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

by Rihawi, Karim, Gelsomino, Francesco, Sperandi, Francesca, Melotti, Barbara, Fiorentino, Michelangelo, Casolari, Laura, Ardizzoni, Andrea
Published in Ther Adv Respir Dis (2017)

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer

by Parisi, Claudia, Lamberti, Giuseppe, Zompatori, Maurizio, Gelsomino, Francesco, Salvagni, Stefania, Sperandi, Francesca, Ardizzoni, Andrea
Published in J Immunother Cancer (2020)

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

by Lamberti, Giuseppe, Sisi, Monia, Andrini, Elisa, Palladini, Arianna, Giunchi, Francesca, Lollini, Pier-Luigi, Ardizzoni, Andrea, Gelsomino, Francesco
Published in Cancers (Basel) (2020)

IFN-γ and CD38 in Hyperprogressive Cancer Development

by Angelicola, Stefania, Ruzzi, Francesca, Landuzzi, Lorena, Scalambra, Laura, Gelsomino, Francesco, Ardizzoni, Andrea, Nanni, Patrizia, Lollini, Pier-Luigi, Palladini, Arianna
Published in Cancers (Basel) (2021)

New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event

by Lamberti, Giuseppe, Gelsomino, Francesco, Brocchi, Stefano, Poerio, Antonio, Melotti, Barbara, Sperandi, Francesca, Gargiulo, Mauro, Borghi, Claudio, Fiorentino, Michelangelo, Ardizzoni, Andrea
Published in Ther Adv Med Oncol (2020)

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

by Ricci, Costantino, Capizzi, Elisa, Giunchi, Francesca, Casolari, Laura, Gelsomino, Francesco, Rihawi, Karim, Natali, Filippo, Livi, Vanina, Trisolini, Rocco, Fiorentino, Michelangelo, Ardizzoni, Andrea
Published in Ther Adv Med Oncol (2020)

Pitfalls in oncology: a unique case of thoracic splenosis mimicking malignancy in a patient with resected breast cancer

by Gelsomino, Francesco, Castellani, Maria Rita, Marchianò, Alfonso, Duca, Matteo, Mariani, Paola, Aliberti, Gianluca, Maccauro, Marco, Duranti, Leonardo, Capri, Giuseppe, de Braud, Filippo Guglielmo, Bianchi, Giulia Valeria
Published in J Thorac Dis (2016)

Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis

by Frascaroli, Giada, Rossini, Giada, Maltoni, Virginia, Bartoletti, Michele, Ortolani, Patrizia, Gredmark-Russ, Sara, Gelsomino, Francesco, Moroni, Alessandra, Silenzi, Silvia, Castellani, Gastone, Sambri, Vittorio, Mastroianni, Antonio, Brune, Wolfram, Varani, Stefania
Published in Front Cell Infect Microbiol (2020)

Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches

by Laprovitera, Noemi, Salamon, Irene, Gelsomino, Francesco, Porcellini, Elisa, Riefolo, Mattia, Garonzi, Marianna, Tononi, Paola, Valente, Sabrina, Sabbioni, Silvia, Fontana, Francesca, Manaresi, Nicolò, D’Errico, Antonia, Pantaleo, Maria A., Ardizzoni, Andrea, Ferracin, Manuela
Published in Front Cell Dev Biol (2021)

Meningitis Caused by Toscana Virus Is Associated with Strong Antiviral Response in the CNS and Altered Frequency of Blood Antigen-Presenting Cells

by Varani, Stefania, Gelsomino, Francesco, Bartoletti, Michele, Viale, Pierluigi, Mastroianni, Antonio, Briganti, Elisabetta, Ortolani, Patrizia, Albertini, Francesco, Calzetti, Carlo, Prati, Francesca, Cenni, Patrizia, Castellani, Gastone, Morini, Silvia, Rossini, Giada, Landini, Maria Paola, Sambri, Vittorio
Published in Viruses (2015)

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

by Cinausero, Marika, Laprovitera, Noemi, De Maglio, Giovanna, Gerratana, Lorenzo, Riefolo, Mattia, Macerelli, Marianna, Fiorentino, Michelangelo, Porcellini, Elisa, Buoro, Vanessa, Gelsomino, Francesco, Squadrilli, Anna, Fasola, Gianpiero, Negrini, Massimo, Tiseo, Marcello, Ferracin, Manuela, Ardizzoni, Andrea
Published in Ther Adv Med Oncol (2019)

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

by Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
Published in Br J Cancer (2020)

Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

by Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
Published in Br J Cancer (2021)

Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)

by Gelsomino, Francesco, Lamberti, Giuseppe, Tiseo, Marcello, Rocco, Danilo, Pasello, Giulia, Cecere, Fabiana Letizia, Chella, Antonio, Grilli, Giada, Mandruzzato, Marcella, Tognetto, Michele, Garassino, Marina Chiara, Macerelli, Marianna, Novello, Silvia, Roila, Fausto, Colantonio, Ida, Grossi, Francesco, Fiorentino, Michelangelo, Ardizzoni, Andrea
Published in Ther Adv Med Oncol (2020)

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

by Passiglia, Francesco, Cappuzzo, Federico, Alabiso, Oscar, Bettini, Anna Cecilia, Bidoli, Paolo, Chiari, Rita, Defferrari, Carlotta, Delmonte, Angelo, Finocchiaro, Giovanna, Francini, Guido, Gelsomino, Francesco, Giannarelli, Diana, Giordano, Monica, Illiano, Alfonso, Livi, Lorenzo, Martelli, Olga, Natoli, Clara, Puppo, Gianfranco, Ricevuto, Enrico, Roca, Elisa, Turci, Daniele, Galetta, Domenico
Published in Br J Cancer (2018)